654 Results

People

  1. Motzer
    Motzer
  2. Mulhall
    Mulhall
  3. Saltz
    Saltz
  4. Hudis
    Hudis
  5. Abou-Alfa
    Abou-Alfa
  6. Lichtman
    Lichtman
  7. De Angelis
    De Angelis
  8. Ginsberg
    Ginsberg
  9. Russo
    Russo
  10. Feldman
    Feldman

Groups

  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)
  7. Division of Subspecialty Medicine (78)
  8. Center for Hematologic Malignancies (77)
  9. Epidemiology and Biostatistics (69)
  10. Radiology, Department of (61)
  1. "hypertension"
Formats
  1. Journal Article (607)
  2. Review (31)
  3. Editorial (6)
  4. Guidelines (4)
  5. Research Letter (3)
  6. Book Section (1)
  7. Conference Paper (1)
  8. Correspondence (1)
Groups
  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)

More Groups

People
  1. Robert Motzer (59)
  2. John Mulhall (21)
  3. Leonard Saltz (18)
  4. Clifford Hudis (16)
  5. Richard Steingart (14)
  6. Ghassan Abou-Alfa (13)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (31)
  4. 2022 (29)
  5. 2021 (23)
  6. 2020 (38)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. Clinical Cancer Research (20)
  3. Lancet Oncology (20)
  4. Cancer (15)
  5. Journal of the National Comprehensive Cancer Network (15)
  6. Journal of Sexual Medicine (14)

More Publications

Publishers
  1. Elsevier Inc. (124)
  2. Elsevier Science, Inc. (58)
  3. Springer (47)
  4. American Society of Clinical Oncology (42)
  5. Oxford University Press (39)
  6. Wiley Blackwell (35)

More Publishers

Results (654)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cabozantinib plus nivolumab in patients with non–clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Journal Article

    Fitzgerald, K. N.; Lee, C. H.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y.; Lefkowitz, R. A.; Shah, N. J.; Owens, C. N.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • The Princeton IV consensus recommendations for the management of erectile dysfunction and cardiovascular disease
    Guidelines

    Köhler, T. S.; Kloner, R. A.; Rosen, R. C.; Burnett, A. L.; Blaha, M. J.; Ganz, P.; Goldstein, I.; Kim, N. N.; Lue, T.; McVary, K. T.; more...
    Mayo Clinic Proceedings (2024)

    Fulltext@MSK | Save
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study
    Journal Article

    Wierda, W. G.; Shah, N. N.; Cheah, C. Y.; Lewis, D.; Hoffmann, M. S.; Coombs, C. C.; Lamanna, N.; Ma, S.; Jagadeesh, D.; Munir, T.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • The incremental contribution of mobile cone-beam computed tomography to the tool–lesion relationship during shape-sensing robotic-assisted bronchoscopy
    Journal Article

    Husta, B. C.; Menon, A.; Bergemann, R.; Lin, I. H.; Schmitz, J.; Rakočević, R.; Nadig, T. R.; Adusumilli, P. S.; Beattie, J. A.; Lee, R. P.; more...
    ERJ Open Research (2024)

    Fulltext@MSK | Save
  • Bruton’s tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): Current progress and latest advances
    Review

    Schaff, L.; Nayak, L.; Grommes, C.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of thermal ablation of adrenal metastases secondary to lung cancer
    Journal Article

    Mendez, A. M.; Petre, E. N.; Ziv, E.; Ridouani, F.; Solomon, S. B.; Sotirchos, V.; Zhao, K.; Alexander, E. S.
    Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Association of acute incidental cerebral microinfarcts with subsequent ischemic stroke in patients with cancer
    Journal Article

    Naftali, J.; Barnea, R.; Leader, A.; Eliahou, R.; Pardo, K.; Tolkovsky, A.; Hasminski, V.; Raphaeli, G.; Bloch, S.; Shochat, T.; more...
    Neurology (2024)

    Fulltext@MSK | Save
  • Da Vinci and Hugo RAS platforms for robot-assisted partial nephrectomy: A preliminary prospective comparative analysis of the outcomes
    Journal Article

    Garcia Rojo, E.; Hevia Palacios, V.; Brime Menendez, R.; Feltes Ochoa, J. A.; Justo Quintas, J.; Lista Mateos, F.; Touijer, K.; Romero Otero, J.
    Minerva Urology and Nephrology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: A retrospective cohort study
    Journal Article

    Yu, J.; Bai, Y.; Cui, Z.; Cheng, C.; Ladekarl, M.; Cheng, K. C.; Chan, K. S.; Yarmohammadi, H.; Mauriz, J. L.; Zhang, Y.
    Journal of Gastrointestinal Oncology (2024)

    Fulltext@MSK | Save
  • Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease
    Journal Article

    Bustamante, M. S.; Pierson, S. K.; Ren, Y.; Bagg, A.; Brandstadter, J. D.; Srkalovic, G.; Mango, N.; Alapat, D.; Lechowicz, M. J.; Li, H.; more...
    Haematologica (2024)

    Fulltext@MSK | Save